| |
 |
Preface [HotTopic: Genomics-Based Anti-Cancer Drug Discovery (Guest Editor: Gayathri R. Devi)]
|
| |
|
pp.i-i (1) Author: Gayathri R. Devi
|
| |
|
|
| |
|
Zebrafish as a Genomics Research Model
|
| |
|
pp.409-413 (5) Authors: Eleanor Chen, Stephen C. Ekker
|
| |
|
|
| |
|
Anti-Genes: siRNA, Ribozymes and Antisense
|
| |
|
pp.415-420 (6) Author: Kevin J. Scanlon
|
| |
|
|
| |
|
Oligonucleotide Mediated Gene Targeting in Mammalian Cells
|
| |
|
pp.421-430 (10) Author: Michael M. Seidman
|
| |
|
|
| |
|
Neutrally Charged Phosphorodiamidate Morpholino Antisense Oligomers: Uptake, Efficacy and Pharmacokinetics
|
| |
|
pp.431-439 (9) Authors: Vikram Arora, Gayathri R. Devi, Patrick L. Iversen
|
| |
|
|
| |
|
The Ins and Outs of RNAi in Mammalian Cells
|
| |
|
pp.441-450 (10) Authors: M. Banan, N. Puri
|
| |
|
|
| |
|
SV40 Pseudovirions as Highly Efficient Vectors for Gene Transfer and their Potential Application in Cancer Therapy
|
| |
|
pp.451-458 (8) Authors: Chava Kimchi-Sarfaty, Michael M. Gottesman
|
| |
|
|
| |
|
Targeting Steroid Hormone Receptor Pathways in the Treatment of Hormone Dependent Cancers
|
| |
|
pp.459-470 (12) Authors: Y. J. Ko, S. P. Balk
|
| |
|
|
| |
|
Role of Genomics-Based Strategies in Overcoming Chemotherapeutic Resistance
|
| |
|
pp.471-480 (10) Authors: M. Vijay Kumar, Robert Shirley, Yulin Ma, Ronald W. Lewis
|
| |
|
|
| |
|
Erratum
|
| |
|
pp.481-481 (1) Author: Lloyd M. Davis
|
| |
|
|
